Stay updated with breaking news from Term Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
03.11.2022 - Robust improvements in key markers of disease sustained across a broad population of adults with paroxysmal nocturnal hemoglobinuria (PNH)WALTHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) - Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global ... Seite 1
Scientific presentations demonstrate argenx’s leadership in FcRn blockade and commitment to innovating for patients across multiple neuromuscular diseases ...
Pivotal results for efficacy and safety of Cosentyx (secukinumab) in hidradenitis suppurativa from Phase III SUNSHINE and SUNRISE trials to be debuted as late-breaker at European Academy of Dermatology
Analyses highlight long-term efficacy and safety results, including real-world data, from studies of SKYRIZI® (risankizumab) in moderate to severe...
11.07.2022 - REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) - Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentations at ... Seite 1